Clifford Chance

Clifford Chance advises on Beauty Farm’s Hong Kong IPO and Listing

Leading international law firm Clifford Chance has advised the joint sponsors Morgan Stanley, Haitong International, and Huatai Financial Holdings on Beauty Farm Medical and Health Industry Inc.’s HK$783 million (US$100 million) initial public offering and listing on the mainboard of the Hong Kong Stock Exchange.

Partners Fang Liu and Virginia Lee led the Clifford Chance team advising on the deal, which also includes counsel Lorna Lyu and Claire Cao, senior associates Qingyu Wu and Joy Chen, associates Belinda Cai, Yaping Li and Yuer Shao, and legal analysts Serena Shen and Hao Lin.

Beauty Farm is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China, as measured by revenue in 2021. It operates a growing nationwide store network consisting of its flagship BeautyFarm brand, as well as emerging brands such as Palaispa, CellCare, and Neology.

The firm's market-leading Greater China IPO practice have advised on the listings of China’s most significant retail and consumer companies, including Giant Biogene (collagen-based professional skincare products), Shanghai Chicmax Cosmetic (skincare, maternity and childcare products) and Weilong Delicious (leading spicy snack food company in China).